Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;14(1):56-64.
doi: 10.1111/jebm.12426. Epub 2021 Feb 17.

The mass production of systematic reviews about COVID-19: An analysis of PROSPERO records

Lara Dotto  1 , Mateus de Azevedo Kinalski  2 , Pablo Soares Machado  3 , Gabriel Kalil Rocha Pereira  3 , Rafael Sarkis-Onofre  1 , Mateus Bertolini Fernandes Dos Santos  2
Affiliations

The mass production of systematic reviews about COVID-19: An analysis of PROSPERO records

Lara Dotto et al. J Evid Based Med. 2021 Feb.

Abstract

Objective: This study aimed to assess the characteristics of different designs of systematic reviews (SRs) registered in the International Prospective Register of Systematic Reviews (PROSPERO) about COVID-19.

Methods: The search was performed in the PROSPERO database using the strategy proposed by the database and considered only human studies. The last date of the search was April 27, 2020. Full text of all records was accessed, and data were extracted by a single researcher, which was further double-checked by another researcher. A descriptive analysis was performed considering record characteristics using tables.

Results: We included 564 records from which the vast majority were registered as SRs (n = 513, 91%). In general, we found poor reporting and missing or confusing information, since 84% of the records (n = 474) did not report the full search that would be adopted, 16% (n = 90) did not report clearly the databases that would be used, and 49.1% (n = 277) did not report the number of primary outcomes. The main focus of most of the records involved clinical, epidemiological, complication, and laboratory characteristics (n = 173, 30.7%) or the treatment of COVID-19 (n = 138, 24.5%).

Conclusion: A large number of SRs about COVID-19 have been conducted, and many of the assessed records were poorly reported and would be difficult to replicate. Besides, collected data points to an epidemic of redundant reviews on COVID-19.

Keywords: quality; register; reporting; systematic reviews.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Glasziou PP, Sanders S, Hoffmann T. Waste in COVID‐19 research. BMJ (Clin Res Ed.). 2020;369:m1847. - PubMed
    1. Alexander PE, Debono VB, Mammen MJ, et al. COVID‐19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine. J Clin Epidemiol. 2020;123:120‐126. - PMC - PubMed
    1. Mehra M, Desai S, Ruschitzka F, Patel A. Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID‐19: a multinational registry analysis. Lancet. 2020. - PMC - PubMed
    1. Mehra MR, Ruschitzka F, Patel AN. Retraction‐Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID‐19: a multinational registry analysis. Lancet. 2020;395:1820. - PMC - PubMed
    1. Gautret P, Lagier JC, Parola P, et al. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID‐19 patients with at least a six‐day follow up: a pilot observational study. Travel Med Infect Dis. 2020;34:101663. - PMC - PubMed